WASHINGTON, Feb. 16, 2026 /PRNewswire/ — The burden, misdiagnosis and delayed treatment of epilepsy highlight an urgent need for improved diagnosis and expanded access to specialized care, according to a new expert-led Clinical Proceedings white paper from the Clinical Neurological Society of America.
Epilepsy is common, with 1 in 26 people in the United States developing the condition. It is characterized by repetitive seizures caused by abnormal electrical activity in the brain and can cause changes in behavior, movements, feelings and levels of consciousness. Because symptoms are often intermittent or non-motor, epilepsy is frequently under-recognized or misdiagnosed, delaying effective treatment. Many patients also develop drug-resistant epilepsy, placing them at a higher risk for injury, disability, mental health conditions and premature death.
The paper, The Impact & Unmet Needs of Epilepsy & the Value of Epilepsy Monitoring Units is authored by leading clinical neurologists and calls for:

- Improving recognition and timely diagnosis of epilepsy
- Expanding access to epilepsy monitoring units (EMUs), specialty epilepsy care; and
- Reducing barriers to treatment to improve quality of life and outcomes for patients and families
- Daniel Friedman, MD (Chair)
- Greogry K. Bergey, MD, FAAN, FANA, FAES, FAAAS
- Tanya Kehoe, PA-C, OTR/L
- Mohamad Koubeissi, MD, MA, FAAN, FANA, FAES
- John Stern, MD, MA, FAAN, FANA, FAES

Source link
















Leave a Reply